JPM23, Day 3: FDA's Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense

11th January 2023 Uncategorised 0

JPM23, Day 3: FDA’s Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense
esagonowsky
Wed, 01/11/2023 – 11:02

More: JPM23, Day 3: FDA's Califf weighs in on accelerated approvals, AbbVie CEO touts Humira defense
Source: fierce